France, Germany struggle to sell AstraZeneca vaccine safety
Already facing a daunting Covid vaccination challenge, French and German authorities are fighting to convince more people that a jab from AstraZeneca is just as effective as others
Global Covid vaccination push gets a shot in the arm
A plan to ensure Covid-19 vaccines reach the world's poorest can finally swing into action after the World Health Organization recently approved the AstraZeneca jab
Vaccine storm engulfs EU chief von der Leyen
EU chief Ursula von der Leyen faces the deepest political crisis of her mandate so far, under intense fire over delayed vaccine deliveries and the bungled roll-out of export controls
More than 100 million vaccinated worldwide
More than 100 million Covid-19 vaccines have been given around the world, an AFP tally has found, but none of the world's 29 poorest countries has formally started mass vaccination drives
Questions surround AstraZeneca vaccine use for elderly
The subject of a sometimes acrimonious row between the EU and Britain, the AstraZeneca Covid-19 vaccine has also fuelled debate over its effectiveness among the elderly
EU warns AstraZeneca over vaccine delivery delay
The European Union has issued an angry warning to pharmaceutical group AstraZeneca over its unexpected delay in delivering millions of doses of its Covid-19 vaccine to the bloc
AstraZeneca, Oxford file for EU vaccine approval
AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the EU with a decision possible by January 29, the European Medicines Agency says
EU watchdog backs second coronavirus vaccine
The EU's drug regulator has approved the Moderna coronavirus jab, the bloc's second and a shot in the arm for Europe's slow-moving vaccine roll-out
Frontrunners emerge in race for Covid-19 vaccine
Positive results from trials of several vaccine candidates have raised hopes that there is light at the end of the tunnel in the quest to curb a pandemic that has already killed 1.4 million
In race for vaccine, safety trumps speed
The halting of clinical trials for one of the most advanced experimental Covid-19 vaccines shows the importance of safety in developing new medicines, experts say